Acta Materia Medica (Mar 2024)

Application of PROTACs in target identification and validation

  • Yang Liu,
  • Jing Liang,
  • Rui Zhu,
  • Yueying Yang,
  • Yali Wang,
  • Wenyi Wei,
  • Hua Li,
  • Lixia Chen

DOI
https://doi.org/10.15212/AMM-2024-0010
Journal volume & issue
Vol. 3, no. 1
pp. 72 – 87

Abstract

Read online

Proteolysis targeting chimeras (PROTACs), as a novel therapeutic drug model, has received widespread attention from academia and the pharmaceutical industry. PROTAC technology has led researchers to focus on developing chemical biology tool properties due to the unique operating mechanism and protein dynamic regulatory properties. In recent years the rapid development of PROTAC technology has gradually made PROTACs an essential tool for target identification and validation. To further promote the application of PROTAC tools in drug discovery and basic medical science research, this review distinguished target identification and validation concepts. Furthermore, research progress in PROTAC technology was summarized.

Keywords